Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Cervical Cancer

  Free Subscription


14.01.2019

7 Acta Cytol
1 Ann Ig
1 Anticancer Res
1 Arch Gynecol Obstet
1 Biol Pharm Bull
1 Biomed Res Int
3 BMC Cancer
1 BMC Res Notes
2 BMC Womens Health
1 Breast Cancer Res Treat
1 Cancer Chemother Pharmacol
1 Cancer Invest
1 Cancer Nurs
1 CMAJ
1 EMBO Rep
1 Eur J Pharm Biopharm
1 Front Microbiol
1 Gene
1 Ginekol Pol
1 Gynecol Obstet Invest
1 Health Sci Rep
1 Int J Biol Macromol
3 Int J Cancer
1 Int J Clin Oncol
1 J BUON
1 J Cell Physiol
1 J Glob Health
1 J Glob Oncol
1 J Immigr Minor Health
1 J Obstet Gynaecol Res
2 J Pediatr Adolesc Gynecol
1 J Pediatr Nurs
1 J Womens Health (Larchmt)
1 Jpn J Clin Oncol
1 Lakartidningen
1 Malawi Med J
1 Med Sci Monit
5 Medicine (Baltimore)
1 MMWR Morb Mortal Wkly Rep
1 Mol Cell
1 Nan Fang Yi Ke Da Xue Xue Bao
1 Pathol Res Pract
1 Pharmaceutics
1 PLoS One
1 Res Synth Methods
1 S Afr Med J
1 Zhonghua Bing Li Xue Za Zhi
1 Zhonghua Yu Fang Yi Xue Za Zhi
1 Zhonghua Zhong Liu Za Zhi


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Cytol

  1. EDBLAD-SVENSSON A, Silfverdal L, Collberg P, Tunon K, et al
    High-Risk Types of Human Papilloma Virus DNA Testing in Women with False Negative Cytology.
    Acta Cytol. 2018;62.
    PubMed     Text format     Abstract available

  2. LEPE M, Eklund CM, Quddus MR, Paquette C, et al
    Atypical Glandular Cells: Interobserver Variability according to Clinical Management.
    Acta Cytol. 2018;62.
    PubMed     Text format     Abstract available

  3. MCHUGH KE, Reynolds JP, Suarez AA
    Postmenopausal Squamous Atypia: Cytologic Features, Hybrid Capture 2 Tests and Contribution to the ASCUS Pool.
    Acta Cytol. 2018;62.
    PubMed     Text format     Abstract available

  4. KOMATSU H, Oishi T, Osaku D, Sawada M, et al
    Significance of High-Risk Human Papillomavirus Testing for Atypical Glandular Cells on Cervical Cytology.
    Acta Cytol. 2018;62.
    PubMed     Text format     Abstract available

  5. OLIVEIRA GG, Oliveira JMDSC, Eleuterio RMN, Barbosa RCC, et al
    Atypical Squamous Cells: Cytopathological Findings and Correlation with HPV Genotype and Histopathology.
    Acta Cytol. 2018;62.
    PubMed     Text format     Abstract available

  6. FISCHER G, Cormier K
    Glandular Cell Abnormalities on SurePath Preparations: A Retrospective Review with Cytology-Histology Correlations.
    Acta Cytol. 2018;62.
    PubMed     Text format     Abstract available

  7. LEITE KRM, Silva T, Naum B, Canavez F, et al
    Validation of a New Low-Cost, Methanol-Based Fixative for Cervical Cytology and Human Papillomavirus Detection.
    Acta Cytol. 2018;62.
    PubMed     Text format     Abstract available


    Ann Ig

  8. BIANCHI FP, Gallone MS, Fortunato F, Boccalini S, et al
    Epidemiology and cost of cervical cancer care and prevention in Apulia (Italy), 2007/2016.
    Ann Ig. 2018;30:490-501.
    PubMed     Text format     Abstract available


    Anticancer Res

  9. ERNSTSON A, Asciutto KC, Sturesson J, Noren J, et al
    Detection of HPV mRNA in Self-collected Vaginal Samples Among Women at 69-70 Years of Age.
    Anticancer Res. 2019;39:381-386.
    PubMed     Text format     Abstract available


    Arch Gynecol Obstet

  10. ZONG S, Liu X, Zhou N, Yue Y, et al
    E2F7, EREG, miR-451a and miR-106b-5p are associated with the cervical cancer development.
    Arch Gynecol Obstet. 2019 Jan 4. pii: 10.1007/s00404-018-5007.
    PubMed     Text format     Abstract available


    Biol Pharm Bull

  11. ZHAO X, Song X, Zhao J, Zhu W, et al
    Juglone inhibits proliferation of HPV-positive cervical cancer cells specifically.
    Biol Pharm Bull. 2018 Dec 28. doi: 10.1248/bpb.b18-00845.
    PubMed     Text format     Abstract available


    Biomed Res Int

  12. HAN MS, Lee JM, Kim SN, Kim JH, et al
    Human Papillomavirus 16 Oncoproteins Downregulate the Expression of miR-148a-3p, miR-190a-5p, and miR-199b-5p in Cervical Cancer.
    Biomed Res Int. 2018;2018:1942867.
    PubMed     Text format     Abstract available


    BMC Cancer

  13. LIU GC, Zhou YF, Su XC, Zhang J, et al
    Interaction between TP53 and XRCC1 increases susceptibility to cervical cancer development: a case control study.
    BMC Cancer. 2019;19:24.
    PubMed     Text format     Abstract available

  14. MABEYA H, Menon S, Weyers S, Naanyu V, et al
    Uptake of three doses of HPV vaccine by primary school girls in Eldoret, Kenya; a prospective cohort study in a malaria endemic setting.
    BMC Cancer. 2018;18:557.
    PubMed     Text format     Abstract available

  15. LOU H, Gharzouzi E, Guerra SP, Domgue JF, et al
    Low-cost HPV testing and the prevalence of cervical infection in asymptomatic populations in Guatemala.
    BMC Cancer. 2018;18:562.
    PubMed     Text format     Abstract available


    BMC Res Notes

  16. PONCE-BENAVENTE L, Rejas-Pinelo P, Aguilar-Luis MA, Palomares-Reyes C, et al
    Frequency and coinfection between genotypes of human papillomavirus in a population of asymptomatic women in northern Peru.
    BMC Res Notes. 2018;11:530.
    PubMed     Text format     Abstract available


    BMC Womens Health

  17. MOODLEY J, Constant D, Botha MH, van der Merwe FH, et al
    Exploring the feasibility of using mobile phones to improve the management of clients with cervical cancer precursor lesions.
    BMC Womens Health. 2019;19:2.
    PubMed     Text format     Abstract available

  18. ALDOHAIAN AI, Alshammari SA, Arafah DM
    Using the health belief model to assess beliefs and behaviors regarding cervical cancer screening among Saudi women: a cross-sectional observational study.
    BMC Womens Health. 2019;19:6.
    PubMed     Text format     Abstract available


    Breast Cancer Res Treat

  19. REGMI S, Fung TS, Lim S, Luo KQ, et al
    Fluidic shear stress increases the anti-cancer effects of ROS-generating drugs in circulating tumor cells.
    Breast Cancer Res Treat. 2018;172:297-312.
    PubMed     Text format     Abstract available


    Cancer Chemother Pharmacol

  20. CHEN X, Xiong D, Ye L, Yang H, et al
    SPP1 inhibition improves the cisplatin chemo-sensitivity of cervical cancer cell lines.
    Cancer Chemother Pharmacol. 2019 Jan 9. pii: 10.1007/s00280-018-3759.
    PubMed     Text format     Abstract available


    Cancer Invest

  21. SHARMA VR, Thomas SD, Miller DM, Rezzoug F, et al
    Nucleolin Overexpression Confers Increased Sensitivity to the Anti-Nucleolin Aptamer, AS1411.
    Cancer Invest. 2018;36.
    PubMed     Text format     Abstract available


    Cancer Nurs

  22. LEE HY, Beltran R, Kim NK, Lee DK, et al
    Racial Disparities in Cervical Cancer Screening: Implications for Relieving Cervical Cancer Burden in Asian American Pacific Islander Women.
    Cancer Nurs. 2019 Jan 8. doi: 10.1097/NCC.0000000000000642.
    PubMed     Text format     Abstract available


    CMAJ

  23. POPADIUK C, Decker K, Gauvreau C
    Starting cervical cancer screening at 25 years of age: the time has come.
    CMAJ. 2019;191:E1-E2.
    PubMed     Text format    


    EMBO Rep

  24. HAZAWA M, Lin DC, Kobayashi A, Jiang YY, et al
    ROCK-dependent phosphorylation of NUP62 regulates p63 nuclear transport and squamous cell carcinoma proliferation.
    EMBO Rep. 2018;19:73-88.
    PubMed     Text format     Abstract available


    Eur J Pharm Biopharm

  25. FRANK LA, Gazzi RP, Mello P, Buffon A, et al
    Imiquimod-loaded nanocapsules improve cytotoxicity in cervical cancer cell line.
    Eur J Pharm Biopharm. 2019 Jan 7. pii: S0939-6411(18)31231.
    PubMed     Text format     Abstract available


    Front Microbiol

  26. MUNOZ JP, Carrillo-Beltran D, Aedo-Aguilera V, Calaf GM, et al
    Tobacco Exposure Enhances Human Papillomavirus 16 Oncogene Expression via EGFR/PI3K/Akt/c-Jun Signaling Pathway in Cervical Cancer Cells.
    Front Microbiol. 2018;9:3022.
    PubMed     Text format     Abstract available


    Gene

  27. YU JH, Shi WW, Zhou MY, Liu JM, et al
    Genetic variability and oncogenic risk association of human papillomavirus type 58 E6 and E7 genes in Taizhou area, China.
    Gene. 2019;686:171-176.
    PubMed     Text format     Abstract available


    Ginekol Pol

  28. GULSEREN V, Kocaer M, Gungorduk O, Ozdemir IA, et al
    Stage IB1 cervical cancer treated with modified radical or radical hysterectomy: does size determine risk factors?
    Ginekol Pol. 2018;89:667-671.
    PubMed     Text format     Abstract available


    Gynecol Obstet Invest

  29. QIN S, Gao Y, Yang Y, Zhang L, et al
    Identifying Molecular Markers of Cervical Cancer Based on Competing Endogenous RNA Network Analysis.
    Gynecol Obstet Invest. 2019 Jan 9:1-10. doi: 10.1159/000493476.
    PubMed     Text format     Abstract available


    Health Sci Rep

  30. SINGLA AA, Komesaroff P
    Self-collected Pap smears may provide an acceptable and effective method of cervical cancer screening.
    Health Sci Rep. 2018;1:e33.
    PubMed     Text format     Abstract available


    Int J Biol Macromol

  31. QIU J, Zhang H, Wang Z
    Auricularia auriculajudae polysaccharide-cisplatin complexes conjugated with folic acid as new tumor targeting agents.
    Int J Biol Macromol. 2018;120.
    PubMed     Text format     Abstract available


    Int J Cancer

  32. DEL MISTRO A, Adcock R, Carozzi F, Gillio-Tos A, et al
    HPV genotyping for the cross-sectional and longitudinal probability of developing CIN2.
    Int J Cancer. 2018 Feb 17. doi: 10.1002/ijc.31326.
    PubMed     Text format     Abstract available

  33. RIETBERGEN MM, van Bokhoven AAJD, Lissenberg-Witte BI, Heideman DAM, et al
    Epidemiologic associations of HPV-positive oropharyngeal cancer and (pre)cancerous cervical lesions.
    Int J Cancer. 2018 Feb 14. doi: 10.1002/ijc.31315.
    PubMed     Text format     Abstract available

  34. LUOSTARINEN T, Apter D, Dillner J, Eriksson T, et al
    Vaccination protects against invasive HPV-associated cancers.
    Int J Cancer. 2017 Dec 26. doi: 10.1002/ijc.31231.
    PubMed     Text format    


    Int J Clin Oncol

  35. YOSHIDA K, Kajiyama H, Yoshihara M, Ikeda Y, et al
    Does postoperative prophylactic irradiation of para-aortic lymph nodes reduce the risk of recurrence in uterine cervical cancer with positive pelvic lymph nodes?
    Int J Clin Oncol. 2019 Jan 5. pii: 10.1007/s10147-018-1376.
    PubMed     Text format     Abstract available


    J BUON

  36. ZHANG Y, Li G, Ji C
    Inhibition of human cervical cancer cell growth by Salviolone is mediated via autophagy induction, cell migration and cell invasion suppression, G2/M cell cycle arrest and downregulation of Nf-kB/m-TOR/PI3K/AKT pathway.
    J BUON. 2018;23:1739-1744.
    PubMed     Text format     Abstract available


    J Cell Physiol

  37. YUAN LY, Qin X, Li L, Zhou J, et al
    Overexpression of LINC00037 represses cervical cancer progression by activating mTOR signaling pathway.
    J Cell Physiol. 2019 Jan 5. doi: 10.1002/jcp.28012.
    PubMed     Text format     Abstract available


    J Glob Health

  38. BHATT S, Isaac R, Finkel M, Evans J, et al
    Mobile technology and cancer screening: Lessons from rural India.
    J Glob Health. 2018;8:020421.
    PubMed     Text format     Abstract available


    J Glob Oncol

  39. KISLING K, Zhang L, Simonds H, Fakie N, et al
    Fully Automatic Treatment Planning for External-Beam Radiation Therapy of Locally Advanced Cervical Cancer: A Tool for Low-Resource Clinics.
    J Glob Oncol. 2019;:1-9.
    PubMed     Text format     Abstract available


    J Immigr Minor Health

  40. ANDERSON A, Taylor Z, Georges R, Carlson-Cosentino M, et al
    Primary Care Physicians' Role in Parental Decision to Vaccinate with HPV Vaccine: Learnings from a South Texas Hispanic Patient Population.
    J Immigr Minor Health. 2018;20:1236-1242.
    PubMed     Text format     Abstract available


    J Obstet Gynaecol Res

  41. SAKAKIBARA A, Matsui K, Katayama T, Higuchi T, et al
    Age-related survival disparity in stage IB and IIB cervical cancer patients.
    J Obstet Gynaecol Res. 2019 Jan 8. doi: 10.1111/jog.13891.
    PubMed     Text format     Abstract available


    J Pediatr Adolesc Gynecol

  42. TOPAZIAN HM, Kundu D, Peebles K, Ramos S, et al
    HPV Vaccination Recommendation Practices among Adolescent Health Care Providers in 5 Countries.
    J Pediatr Adolesc Gynecol. 2018;31:575-582.
    PubMed     Text format     Abstract available

  43. DEGAREGE A, Krupp K, Fennie K, Srinivas V, et al
    Human Papillomavirus Vaccine Acceptability among Parents of Adolescent Girls in a Rural Area, Mysore, India.
    J Pediatr Adolesc Gynecol. 2018;31:583-591.
    PubMed     Text format     Abstract available


    J Pediatr Nurs

  44. CARHART MY, Schminkey DL, Mitchell EM, Keim-Malpass J, et al
    Barriers and Facilitators to Improving Virginia's HPV Vaccination Rate: A Stakeholder Analysis With Implications for Pediatric Nurses.
    J Pediatr Nurs. 2018;42:1-8.
    PubMed     Text format     Abstract available


    J Womens Health (Larchmt)

  45. MACLAUGHLIN KL, Jacobson RM, Radecki Breitkopf C, Wilson PM, et al
    Trends Over Time in Pap and Pap-HPV Cotesting for Cervical Cancer Screening.
    J Womens Health (Larchmt). 2019 Jan 7. doi: 10.1089/jwh.2018.7380.
    PubMed     Text format     Abstract available


    Jpn J Clin Oncol

  46. ISHIKAWA M, Nakamura K, Shibata T, Tanaka K, et al
    A randomized phase II/III trial of conventional paclitaxel and carboplatin with or without bevacizumab vs dose-dense paclitaxel and carboplatin with or without bevacizumab, in stage IVB, recurrent or persistent cervical carcinoma: Japan Clinical Oncol
    Jpn J Clin Oncol. 2018;48:1096-1100.
    PubMed     Text format     Abstract available


    Lakartidningen

  47. WILANDER E

    Lakartidningen. 2018;115.
    PubMed     Text format    


    Malawi Med J

  48. PFAFF C, Singano V, Akello H, Amberbir A, et al
    Early experiences in integrating cervical cancer screening and treatment into HIV services in Zomba Central Hospital, Malawi.
    Malawi Med J. 2018;30:211-214.
    PubMed     Text format     Abstract available


    Med Sci Monit

  49. CHEN Y, Xiong X, Wang Y, Zhao J, et al
    Proteomic Screening for Serum Biomarkers for Cervical Cancer and Their Clinical Significance.
    Med Sci Monit. 2019;25:288-297.
    PubMed     Text format     Abstract available


    Medicine (Baltimore)

  50. HU Y, Sun B, Zhao B, Mei D, et al
    Cisplatin-induced cardiotoxicity with midrange ejection fraction: A case report and review of the literature.
    Medicine (Baltimore). 2018;97:e13807.
    PubMed     Text format     Abstract available

  51. WEN X, Wen D, Yang Y, Chen Y, et al
    Urban-rural disparity in cervical cancer in China and feasible interventions for tackling the rural excess.
    Medicine (Baltimore). 2019;98:e13907.
    PubMed     Text format     Abstract available

  52. YE F, Wang H, Liu J, Cheng Q, et al
    Genetic polymorphism (rs246079) of the DNA repair gene uracil N-glycosylase is associated with increased risk of cervical carcinoma in a Chinese population.
    Medicine (Baltimore). 2018;97:e13694.
    PubMed     Text format     Abstract available

  53. BYUN JM, Jeong DH, Kim YN, Jung EJ, et al
    Persistent HPV-16 infection leads to recurrence of high-grade cervical intraepithelial neoplasia.
    Medicine (Baltimore). 2018;97:e13606.
    PubMed     Text format     Abstract available

  54. REYNEL M, Villegas Y, Kiene H, Werthmann PG, et al
    Intralesional and subcutaneous application of Viscum album L. (European mistletoe) extract in cervical carcinoma in situ: A CARE compliant case report.
    Medicine (Baltimore). 2018;97:e13420.
    PubMed     Text format     Abstract available


    MMWR Morb Mortal Wkly Rep

  55. VAN DYNE EA, Hallowell BD, Saraiya M, Senkomago V, et al
    Establishing Baseline Cervical Cancer Screening Coverage - India, 2015-2016.
    MMWR Morb Mortal Wkly Rep. 2019;68:14-19.
    PubMed     Text format     Abstract available


    Mol Cell

  56. ALEKSANDROV R, Dotchev A, Poser I, Krastev D, et al
    Protein Dynamics in Complex DNA Lesions.
    Mol Cell. 2018;69:1046-1061.
    PubMed     Text format     Abstract available


    Nan Fang Yi Ke Da Xue Xue Bao

  57. LI X, Li S, Wang X, Zhao S, et al
    [Knocking down fascin inhibits cervical cancer cell proliferation and tumorigenesis in nude mice].
    Nan Fang Yi Ke Da Xue Xue Bao. 2018;38:1409-1414.
    PubMed     Text format     Abstract available


    Pathol Res Pract

  58. JI N, Wang Y, Bao G, Yan J, et al
    LncRNA SNHG14 promotes the progression of cervical cancer by regulating miR-206/YWHAZ.
    Pathol Res Pract. 2018 Dec 26. pii: S0344-0338(18)31432.
    PubMed     Text format     Abstract available


    Pharmaceutics

  59. CI LQ, Huang ZG, Lv FM, Wang J, et al
    Enhanced Delivery of Imatinib into Vaginal Mucosa via a New Positively Charged Nanocrystal-Loaded in Situ Hydrogel Formulation for Treatment of Cervical Cancer.
    Pharmaceutics. 2019;11.
    PubMed     Text format     Abstract available


    PLoS One

  60. MACHIDA H, Matsuo K, Furusawa A, Kita T, et al
    Profile of treatment-related complications in women with clinical stage IB-IIB cervical cancer: A nationwide cohort study in Japan.
    PLoS One. 2019;14:e0210125.
    PubMed     Text format     Abstract available


    Res Synth Methods

  61. FREEMAN SC, Fisher D, Tierney JF, Carpenter JR, et al
    A framework for identifying treatment-covariate interactions in individual participant data network meta-analysis.
    Res Synth Methods. 2018;9:393-407.
    PubMed     Text format     Abstract available


    S Afr Med J

  62. SAIDU R, Moodley J, Tergas A, Momberg M, et al
    South African women's perspectives on self-sampling for cervical cancer screening: A mixed-methods study.
    S Afr Med J. 2018;109:47-52.
    PubMed     Text format     Abstract available


    Zhonghua Bing Li Xue Za Zhi

  63. GU WY, Tao X, Zhang LL, Wang L, et al
    [Synchronous mucinous metaplasia and neoplasia of the female genital tract].
    Zhonghua Bing Li Xue Za Zhi. 2018;47:845-850.
    PubMed     Text format     Abstract available


    Zhonghua Yu Fang Yi Xue Za Zhi

  64. ZHAO FH, Zhang L
    [Prophylactic human papilloma virus vaccines launch the era of comprehensive cervical cancer control].
    Zhonghua Yu Fang Yi Xue Za Zhi. 2019;53:10-12.
    PubMed     Text format     Abstract available


    Zhonghua Zhong Liu Za Zhi

  65. GUO GZ, Zhao Y
    [Analysis of cervical cancer screening results in women aged 50 and older in Beijing and Guizhou].
    Zhonghua Zhong Liu Za Zhi. 2018;40:922-926.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: